CLINICAL_TRIALS
trial_result
· 2018-10-23
Clinical Trial Update: A Study of LY2216684 in Major Depressive Disorder in Patients Taking Selective Serotonin Reuptake Inhibitors [Phase 1]
Summary
A Phase 1 trial evaluating LY2216684 in adults with major depressive disorder who are taking SSRIs has completed, with results posted in 2018.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Eli Lilly and Company | Conditions: Major Depressive Disorder | Phase 1 | Status: COMPLETED | Results posted: 2018-10-23